Biotech | April 11, 2022
Lonza signs manufacturing deal with Asher Biotherapeutics
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
The acquisition will strengthen Lupin’s India formulation business by adding a fast-growing portfolio of vitamins, minerals, supplements and neurological products
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
Trescal provides precision calibration expertise in every industry, geography and instrument across the world
It is currently available in tablet and injectable dosage forms
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
The new structure further transitions the Health Care business line into a system solutions partner for the pharmaceutical and biotech industries
Arzeda harnesses the power of computer-designed enzymes and applies the latest advances in digital biology
Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Subscribe To Our Newsletter & Stay Updated
